IMA Wealth Inc. Sells 255 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)

IMA Wealth Inc. cut its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,517 shares of the company’s stock after selling 255 shares during the period. IMA Wealth Inc.’s […]

Related Keywords

Samarth Kulkarni ,Jamesr Kasinger ,Capital International Investors ,Barclays ,Nasdaq ,Blackrock Inc ,T Rowe Price Investment Management Inc ,Securities Exchange Commission ,Ima Wealth Inc ,Therapeutics Company Profile ,Wealth Inc ,Pricet Rowe Associates Inc ,Free Report ,International Investors ,Rowe Price Investment Management ,State Street Corp ,Street Corp ,Trading Down ,Get Free Report ,Chardan Capital ,General Counsel James ,Visit Holdingschannel ,Crispr Therapeutics ,Nasdaq Crsp ,Crsp ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,